These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11673037)

  • 1. Liposomes and PLG microparticles as sustained release antitubercular drug carriers--an in vitro-in vivo study.
    Dutt M; Khuller GK
    Int J Antimicrob Agents; 2001 Sep; 18(3):245-52. PubMed ID: 11673037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis.
    Dutt M; Khuller GK
    Int J Antimicrob Agents; 2001 Feb; 17(2):115-22. PubMed ID: 11165115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles.
    Dutt M; Khuller GK
    J Antimicrob Chemother; 2001 Jun; 47(6):829-35. PubMed ID: 11389115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly (DL-lactide-co-glycolide) microparticles as carriers for antimycobacterial drug rifampicin.
    Dutt M; Khuller GK
    Indian J Exp Biol; 2000 Sep; 38(9):887-94. PubMed ID: 12561946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of poly [DL-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s).
    Ain Q; Sharma S; Garg SK; Khuller GK
    Int J Pharm; 2002 Jun; 239(1-2):37-46. PubMed ID: 12052689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes.
    Labana S; Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2002 Oct; 20(4):301-4. PubMed ID: 12385689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis.
    Pandey R; Zahoor A; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2003; 83(6):373-8. PubMed ID: 14623168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of Poly(DL-lactide-Co-Glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice.
    Dutt M; Khuller GK
    Antimicrob Agents Chemother; 2001 Jan; 45(1):363-6. PubMed ID: 11121000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
    Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH
    Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.
    Xu W; Wei X; Wei K; Cao X; Zhong S
    Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic efficacy of nanoparticle encapsulated antitubercular drugs.
    Pandey R; Sharma S; Khuller GK
    Drug Deliv; 2006; 13(4):287-94. PubMed ID: 16766470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and safety evaluation of the use of ciprofloxacin on an isoniazid-rifampicin regimen in rabbits.
    Padilha EC; Pires RV; Filho MA; de Pontes Machado DV; Baldan HM; Davanço MG; Campos ML; Brunetti IL; Peccinini RG
    Biopharm Drug Dispos; 2012 Dec; 33(9):501-9. PubMed ID: 23007681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy.
    Gürsoy A; Kut E; Ozkirimli S
    Int J Pharm; 2004 Mar; 271(1-2):115-23. PubMed ID: 15129978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective effect of Anacyclus pyrethrum Linn. against antitubercular drug-induced hepatotoxicity in SD rats.
    Usmani A; Mujahid M; Khushtar M; Siddiqui HH; Rahman MA
    J Complement Integr Med; 2016 Sep; 13(3):295-300. PubMed ID: 27101559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
    Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
    J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
    Sharma A; Sharma S; Khuller GK
    J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung specific stealth liposomes as antitubercular drug carriers in guinea pigs.
    Pandey R; Sharma S; Khuller GK
    Indian J Exp Biol; 2004 Jun; 42(6):562-6. PubMed ID: 15260105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design.
    Chawla R; Jaiswal S; Mishra B
    Expert Opin Drug Deliv; 2014 Jan; 11(1):31-43. PubMed ID: 23802585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hot aqueous leaf extract of Lasianthera africana (Icacinaceae) attenuates rifampicin-isoniazid-induced hepatotoxicity.
    Nwidu LL; Teme RE
    J Integr Med; 2018 Jul; 16(4):263-272. PubMed ID: 29776838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.